ArticleDiabetes2010

Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy.

Jinhua Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.